WET AGE RELATED MACULAR DEGENERATION
Clinical trials for WET AGE RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could end monthly eye injections for wet AMD
Disease control Recruiting nowThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 714 adults aged 50-89 who currently need regular eye injections will receive either the gene therapy or standard treatment. The goal is to…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New hope for wet AMD patients: a simple pill may drain stubborn eye fluid
Disease control Recruiting nowThis study tests whether an oral medication (doxycycline) can help people with wet age-related macular degeneration (AMD) who still have fluid under their retina despite standard eye injections. About 50 participants will receive either doxycycline or a placebo for several months…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New Eye-Tracking tech could let AMD patients monitor vision loss from home
Diagnosis Recruiting nowThis study is testing a home-based eye-tracking system called AVIGA to see if it can detect when wet age-related macular degeneration (AMD) comes back. Sixty adults aged 50-99 who are being treated for wet AMD will use the AVIGA device at home, and its accuracy will be compared t…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Scientists swab eyes to map the 'Microbiome' of healthy and diseased eyes
Knowledge-focused Recruiting nowThis study aims to understand the natural bacteria living on the surface of the eye in both healthy people and those with certain eye conditions. Researchers will collect eye swabs from 500 adults in middle Tennessee to build a database of what a normal eye microbiome looks like.…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can your genes predict which eye drug works best?
Knowledge-focused Recruiting nowThis phase 3 trial is testing whether a person's genetic makeup influences how well they respond to two standard drugs for wet age-related macular degeneration: ranibizumab and bevacizumab. About 630 patients will receive one of the two drugs and be followed for three years. The …
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC